{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T20:03:42Z","timestamp":1793736222224,"version":"4.6.1"},"reference-count":88,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:00:00Z","timestamp":1782950400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Forschung Technologie und Raumfahrt Informationstechnikzentrum Bund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.biopha.2026.119738","type":"journal-article","created":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T04:19:39Z","timestamp":1783397979000},"page":"119738","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Acid sphingomyelinase is an age-dependent host cell factor for adenovirus entry and a pharmacological target for synergistic combination therapy with brincidofovir"],"prefix":"10.1016","volume":"201","author":[{"given":"Sophie","family":"Post","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Zamzamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-3425-0817","authenticated-orcid":false,"given":"Luca","family":"Benthien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena","family":"Rueschpler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wing Hang","family":"Ip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0505-533X","authenticated-orcid":false,"given":"Elin","family":"Hahlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"K\u00fchn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8849-1064","authenticated-orcid":false,"given":"Christian","family":"Conze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelique","family":"Hoelzemer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Dobner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niklas","family":"Arnberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"Altfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Schloer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.biopha.2026.119738_bib1","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00026-18","article-title":"Interaction of human enterochromaffin cells with human enteric adenovirus 41 leads to serotonin release and subsequent activation of enteric glia cells","volume":"92","author":"Westerberg","year":"2018","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119738_bib2","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines6010030","article-title":"The repertoire of adenovirus in human disease: the innocuous to the deadly","volume":"6","author":"Khanal","year":"2018","journal-title":"Biomedicines"},{"issue":"12","key":"10.1016\/j.biopha.2026.119738_bib3","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.mpmed.2017.09.016","article-title":"Adenovirus infections","volume":"45","author":"Arnold","year":"2017","journal-title":"Medicine"},{"issue":"6","key":"10.1016\/j.biopha.2026.119738_bib4","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/rmv.589","article-title":"Clinical features and treatment of adenovirus infections","volume":"18","author":"Lenaerts","year":"2008","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.biopha.2026.119738_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2021.105034","article-title":"Emerging antiviral therapeutics for human adenovirus infection: Recent developments and novel strategies","volume":"188","author":"Dodge","year":"2021","journal-title":"Antivir. Res."},{"issue":"10","key":"10.1016\/j.biopha.2026.119738_bib6","doi-asserted-by":"crossref","first-page":"3343","DOI":"10.3390\/ph3103343","article-title":"Anti-viral drugs for human adenoviruses","volume":"3","author":"Waye","year":"2010","journal-title":"Pharmaceuticals"},{"issue":"6","key":"10.1016\/j.biopha.2026.119738_bib7","doi-asserted-by":"crossref","first-page":"e364","DOI":"10.1097\/MPH.0000000000001227","article-title":"Brincidofovir (CMX001) toxicity associated with epithelial apoptosis and crypt drop out in a hematopoietic cell transplant patient: challenges in distinguishing drug toxicity from GVHD","volume":"40","author":"Detweiler","year":"2018","journal-title":"J. Pediatr. Hematol. Oncol."},{"issue":"3","key":"10.1016\/j.biopha.2026.119738_bib8","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s00430-019-00645-2","article-title":"Human adenovirus binding to host cell receptors: a structural view","volume":"209","author":"Stasiak","year":"2020","journal-title":"Med. Microbiol. Immunol."},{"issue":"4","key":"10.1016\/j.biopha.2026.119738_bib9","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1128\/JVI.02014-12","article-title":"Host cell autophagy modulates early stages of adenovirus infections in airway epithelial cells","volume":"87","author":"Zeng","year":"2013","journal-title":"J. Virol."},{"issue":"2","key":"10.1016\/j.biopha.2026.119738_bib10","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.virol.2008.10.016","article-title":"Insights into adenovirus host cell interactions from structural studies","volume":"384","author":"Nemerow","year":"2009","journal-title":"Virology"},{"issue":"6","key":"10.1016\/j.biopha.2026.119738_bib11","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1083\/jcb.200112067","article-title":"Adenovirus triggers macropinocytosis and endosomal leakage together with its clathrin-mediated uptake","volume":"158","author":"Meier","year":"2002","journal-title":"J. Cell Biol."},{"issue":"10","key":"10.1016\/j.biopha.2026.119738_bib12","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.00770-23","article-title":"Efficient clathrin-mediated entry of enteric adenoviruses in human duodenal cells","volume":"97","author":"Becker","year":"2023","journal-title":"J. Virol."},{"issue":"S1","key":"10.1016\/j.biopha.2026.119738_bib13","doi-asserted-by":"crossref","first-page":"S152","DOI":"10.1002\/jgm.553","article-title":"Adenovirus endocytosis","volume":"6","author":"Meier","year":"2004","journal-title":"J. Gene Med."},{"issue":"13","key":"10.1016\/j.biopha.2026.119738_bib14","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1016\/j.jmb.2018.04.039","article-title":"Glycomics and proteomics approaches to investigate early adenovirus-host cell interactions","volume":"430","author":"Lasswitz","year":"2018","journal-title":"J. Mol. Biol."},{"issue":"5304","key":"10.1016\/j.biopha.2026.119738_bib15","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1126\/science.275.5304.1320","article-title":"Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5","volume":"275","author":"Bergelson","year":"1997","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.biopha.2026.119738_bib16","doi-asserted-by":"crossref","first-page":"3352","DOI":"10.1073\/pnas.94.7.3352","article-title":"HCAR and MCAR: the human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses","volume":"94","author":"Tomko","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"11","key":"10.1016\/j.biopha.2026.119738_bib17","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1038\/nm952","article-title":"CD46 is a cellular receptor for group B adenoviruses","volume":"9","author":"Gaggar","year":"2003","journal-title":"Nat. Med."},{"issue":"17","key":"10.1016\/j.biopha.2026.119738_bib18","doi-asserted-by":"crossref","first-page":"9183","DOI":"10.1128\/JVI.77.17.9183-9191.2003","article-title":"Adenovirus type 11 uses CD46 as a cellular receptor","volume":"77","author":"Segerman","year":"2003","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119738_bib19","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/nm.2270","article-title":"Desmoglein 2 is a receptor for adenovirus serotypes 3, 7, 11 and 14","volume":"17","author":"Wang","year":"2011","journal-title":"Nat. Med."},{"issue":"2","key":"10.1016\/j.biopha.2026.119738_bib20","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/0092-8674(93)90231-E","article-title":"Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment","volume":"73","author":"Wickham","year":"1993","journal-title":"Cell"},{"issue":"11","key":"10.1016\/j.biopha.2026.119738_bib21","doi-asserted-by":"crossref","first-page":"5405","DOI":"10.1128\/JVI.75.11.5405-5409.2001","article-title":"Integrin alpha(v)beta1 is an adenovirus coreceptor","volume":"75","author":"Li","year":"2001","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119738_bib22","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1083\/jcb.127.1.257","article-title":"Integrin alpha v beta 5 selectively promotes adenovirus mediated cell membrane permeabilization","volume":"127","author":"Wickham","year":"1994","journal-title":"J. Cell Biol."},{"issue":"11","key":"10.1016\/j.biopha.2026.119738_bib23","doi-asserted-by":"crossref","first-page":"8669","DOI":"10.1128\/JVI.72.11.8669-8675.1998","article-title":"Interactions of soluble recombinant integrin alphav beta5 with human adenoviruses","volume":"72","author":"Mathias","year":"1998","journal-title":"J. Virol."},{"issue":"10","key":"10.1016\/j.biopha.2026.119738_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000189","article-title":"Role of cellular heparan sulfate proteoglycans in infection of human adenovirus serotype 3 and 35","volume":"4","author":"Tuve","year":"2008","journal-title":"PLoS Pathog."},{"issue":"18","key":"10.1016\/j.biopha.2026.119738_bib25","doi-asserted-by":"crossref","first-page":"8772","DOI":"10.1128\/JVI.75.18.8772-8780.2001","article-title":"Heparan sulfate glycosaminoglycans are receptors sufficient to mediate the initial binding of adenovirus types 2 and 5","volume":"75","author":"Dechecchi","year":"2001","journal-title":"J. Virol."},{"issue":"2","key":"10.1016\/j.biopha.2026.119738_bib26","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1006\/viro.1999.0171","article-title":"Heparan sulfate glycosaminoglycans are involved in adenovirus type 5 and 2-host cell interactions","volume":"268","author":"Dechecchi","year":"2000","journal-title":"Virology"},{"issue":"4","key":"10.1016\/j.biopha.2026.119738_bib27","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/mmi.14909","article-title":"Adenovirus entry: stability, uncoating, and nuclear import","volume":"118","author":"Greber","year":"2022","journal-title":"Mol. Microbiol."},{"issue":"15","key":"10.1016\/j.biopha.2026.119738_bib28","doi-asserted-by":"crossref","DOI":"10.1242\/jcs.216259","article-title":"Viral escape from endosomes and host detection at a glance","volume":"131","author":"Staring","year":"2018","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.biopha.2026.119738_bib29","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/B978-0-12-386487-1.00002-X","article-title":"Studying lipids involved in the endosomal pathway","volume":"108","author":"Bissig","year":"2012","journal-title":"Methods Cell Biol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119738_bib30","doi-asserted-by":"crossref","first-page":"9","DOI":"10.29245\/2578-3009\/2018\/1.1112","article-title":"Human adenoviruses, cholesterol trafficking, and NF-kappaB signaling","volume":"2","author":"Cianciola","year":"2018","journal-title":"J. Immunol. Sci."},{"issue":"11","key":"10.1016\/j.biopha.2026.119738_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2024.107808","article-title":"Sphingolipids containing very long-chain fatty acids regulate Ypt7 function during the tethering stage of vacuole fusion","volume":"300","author":"Zhang","year":"2024","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.biopha.2026.119738_bib32","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms3250","article-title":"Phosphatidylinositol-3-phosphate regulates sorting and processing of amyloid precursor protein through the endosomal system","volume":"4","author":"Morel","year":"2013","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.biopha.2026.119738_bib33","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.molcel.2010.10.005","article-title":"Membranes in balance: mechanisms of sphingolipid homeostasis","volume":"40","author":"Breslow","year":"2010","journal-title":"Mol. Cell"},{"issue":"1","key":"10.1016\/j.biopha.2026.119738_bib34","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.chom.2015.06.006","article-title":"Co-option of membrane wounding enables virus penetration into cells","volume":"18","author":"Luisoni","year":"2015","journal-title":"Cell Host Microbe"},{"issue":"8","key":"10.1016\/j.biopha.2026.119738_bib35","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms7080216","article-title":"New insights to adenovirus-directed innate immunity in respiratory epithelial cells","volume":"7","author":"Carlin","year":"2019","journal-title":"Microorganisms"},{"key":"10.1016\/j.biopha.2026.119738_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2025.108051","article-title":"Endolysosomes as a sorting hub for emerging viruses: gatekeepers of cellular defense, viral fate and promising therapeutic target","volume":"222","author":"Post","year":"2025","journal-title":"Pharmacol. Res."},{"issue":"11","key":"10.1016\/j.biopha.2026.119738_bib37","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1111\/bph.15418","article-title":"Drug synergy of combinatory treatment with remdesivir and the repurposed drugs fluoxetine and itraconazole effectively impairs SARS-CoV-2 infection in vitro","volume":"178","author":"Schloer","year":"2021","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119738_bib38","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1080\/22221751.2021.2020598","article-title":"Pharmacologically induced endolysosomal cholesterol imbalance through clinically licensed drugs itraconazole and fluoxetine impairs Ebola virus infection in vitro","volume":"11","author":"Kummer","year":"2022","journal-title":"Emerg. Microbes Infect."},{"issue":"1","key":"10.1016\/j.biopha.2026.119738_bib39","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1080\/22221751.2020.1829082","article-title":"Targeting the endolysosomal host-SARS-CoV-2 interface by clinically licensed functional inhibitors of acid sphingomyelinase (FIASMA) including the antidepressant fluoxetine","volume":"9","author":"Schloer","year":"2020","journal-title":"Emerg. Microbes Infect."},{"issue":"9","key":"10.1016\/j.biopha.2026.119738_bib40","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13091400","article-title":"Combination therapy with fluoxetine and the nucleoside analog GS-441524 exerts synergistic antiviral effects against different SARS-CoV-2 variants in vitro","volume":"13","author":"Brunotte","year":"2021","journal-title":"Pharmaceutics"},{"issue":"7","key":"10.1016\/j.biopha.2026.119738_bib41","doi-asserted-by":"crossref","DOI":"10.3390\/ph14070691","article-title":"Update on functional inhibitors of acid sphingomyelinase (FIASMAs) in SARS-CoV-2 infection","volume":"14","author":"Loas","year":"2021","journal-title":"Pharmaceuticals"},{"issue":"10","key":"10.1016\/j.biopha.2026.119738_bib42","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.01958-25","article-title":"Proviral functions of HMGB1 in HAdV-C5 replication compartments","volume":"13","author":"Hidalgo","year":"2025","journal-title":"Microbiol. Spectr."},{"issue":"1","key":"10.1016\/j.biopha.2026.119738_bib43","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/01.inf.0000148882.97399.79","article-title":"Quantitation of adenovirus genome during acute infection in normal children","volume":"24","author":"Shike","year":"2005","journal-title":"Pediatr. Infect. Dis. J."},{"issue":"7","key":"10.1016\/j.biopha.2026.119738_bib44","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms13071670","article-title":"Medical comorbidities as the independent risk factors of severe adenovirus respiratory tract infection in adults","volume":"13","author":"Kwok","year":"2025","journal-title":"Microorganisms"},{"key":"10.1016\/j.biopha.2026.119738_bib45","article-title":"Inhibition of adenovirus transport from the endosome to the cell nucleus by rotenone","volume":"14","author":"Balsera-Manzanero","year":"2023","journal-title":"Front. Pharmacol."},{"issue":"22","key":"10.1016\/j.biopha.2026.119738_bib46","doi-asserted-by":"crossref","first-page":"12367","DOI":"10.1128\/JVI.01833-13","article-title":"A direct and versatile assay measuring membrane penetration of adenovirus in single cells","volume":"87","author":"Suomalainen","year":"2013","journal-title":"J. Virol."},{"issue":"10","key":"10.1016\/j.biopha.2026.119738_bib47","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13713","article-title":"Reduced endosomal microautophagy activity in aging associates with enhanced exocyst-mediated protein secretion","volume":"21","author":"Krause","year":"2022","journal-title":"Aging Cell"},{"issue":"12","key":"10.1016\/j.biopha.2026.119738_bib48","doi-asserted-by":"crossref","DOI":"10.3390\/cells11121977","article-title":"Age-related lysosomal dysfunctions","volume":"11","author":"Guerrero-Navarro","year":"2022","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.biopha.2026.119738_bib49","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1146\/annurev-virology-092818-015550","article-title":"Adenovirus entry: from infection to immunity","volume":"6","author":"Greber","year":"2019","journal-title":"Annu. Rev. Virol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119738_bib50","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/cmi.12053","article-title":"Adenovirus signalling in entry","volume":"15","author":"Wolfrum","year":"2013","journal-title":"Cell. Microbiol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119738_bib51","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1038\/s41467-021-22111-5","article-title":"Molecular basis of V-ATPase inhibition by bafilomycin A1","volume":"12","author":"Wang","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2026.119738_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2025.106079","article-title":"Seeking innovative concepts in development of antiviral drug combinations","volume":"234","author":"Kainov","year":"2025","journal-title":"Antivir. Res."},{"issue":"7","key":"10.1016\/j.biopha.2026.119738_bib53","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1111\/bph.70258","article-title":"Synergistic antiviral activity against human adenovirus through combination of itraconazole and brincidofovir","volume":"183","author":"Zamzamy","year":"2026","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.biopha.2026.119738_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.virol.2024.110367","article-title":"Multiple sphingolipid-metabolizing enzymes modulate influenza virus replication","volume":"603","author":"McKenna","year":"2025","journal-title":"Virology"},{"issue":"4","key":"10.1016\/j.biopha.2026.119738_bib55","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1128\/JVI.79.4.1992-2000.2005","article-title":"Adenovirus protein VI mediates membrane disruption following capsid disassembly","volume":"79","author":"Wiethoff","year":"2005","journal-title":"J. Virol."},{"issue":"8","key":"10.1016\/j.biopha.2026.119738_bib56","doi-asserted-by":"crossref","first-page":"3802","DOI":"10.1128\/JVI.02568-15","article-title":"Virus and host mechanics support membrane penetration and cell entry","volume":"90","author":"Greber","year":"2016","journal-title":"J. Virol."},{"key":"10.1016\/j.biopha.2026.119738_bib57","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.virol.2015.03.006","article-title":"Adenovirus membrane penetration: tickling the tail of a sleeping dragon","volume":"479-480","author":"Wiethoff","year":"2015","journal-title":"Virology"},{"key":"10.1016\/j.biopha.2026.119738_bib58","series-title":"Biology of Adenovirus Cell Entry","first-page":"27","author":"Luisoni","year":"2016"},{"issue":"12","key":"10.1016\/j.biopha.2026.119738_bib59","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1194\/jlr.M054528","article-title":"Acid sphingomyelinase activity is regulated by membrane lipids and facilitates cholesterol transfer by NPC2","volume":"55","author":"Oninla","year":"2014","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.biopha.2026.119738_bib60","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2021.631274","article-title":"Membrane rafts: portals for viral entry","volume":"12","author":"Ripa","year":"2021","journal-title":"Front. Microbiol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119738_bib61","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.bbamem.2008.07.030","article-title":"Ceramide-enriched membrane domains\u2013structure and function","volume":"1788","author":"Zhang","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"issue":"6","key":"10.1016\/j.biopha.2026.119738_bib62","doi-asserted-by":"crossref","first-page":"3089","DOI":"10.1128\/JVI.78.6.3089-3098.2004","article-title":"Cholesterol is required for endocytosis and endosomal escape of adenovirus type 2","volume":"78","author":"Imelli","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.biopha.2026.119738_bib63","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2025.1670356","article-title":"Cholesterol in viral envelope determines infectivity of SARS-CoV-2 and other coronaviruses","volume":"16","author":"Xu","year":"2025","journal-title":"Front. Microbiol."},{"issue":"8","key":"10.1016\/j.biopha.2026.119738_bib64","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1021\/acsinfecdis.4c00085","article-title":"Cholesterol-dependent membrane deformation by metastable viral capsids facilitates entry","volume":"10","author":"Jiao","year":"2024","journal-title":"ACS Infect. Dis."},{"issue":"6","key":"10.1016\/j.biopha.2026.119738_bib65","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02323-20","article-title":"Roles of cholesterol in early and late steps of the nipah virus membrane fusion cascade","volume":"95","author":"Contreras","year":"2021","journal-title":"J. Virol."},{"key":"10.1016\/j.biopha.2026.119738_bib66","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2021.750544","article-title":"Endosomal cholesterol in viral infections \u2013 a common denominator?","volume":"12","author":"Glitscher","year":"2021","journal-title":"Front. Physiol."},{"key":"10.1016\/j.biopha.2026.119738_bib67","article-title":"Modulating cholesterol-rich lipid rafts to disrupt influenza A virus infection","volume":"13","author":"Li","year":"2022","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119738_bib68","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1080\/22221751.2022.2117101","article-title":"3D ex vivo tissue platforms to investigate the early phases of influenza a virus- and SARS-CoV-2-induced respiratory diseases","volume":"11","author":"Schloer","year":"2022","journal-title":"Emerg. Microbes Infect."},{"key":"10.1016\/j.biopha.2026.119738_bib69","doi-asserted-by":"crossref","first-page":"477","DOI":"10.12688\/f1000research.53275.2","article-title":"Fluoxetine pharmacokinetics and tissue distribution quantitatively supports a therapeutic role in COVID-19 at a minimum dose of 20 mg per day","volume":"10","author":"Eugene","year":"2022","journal-title":"F1000Research"},{"issue":"3","key":"10.1016\/j.biopha.2026.119738_bib70","doi-asserted-by":"crossref","first-page":"201","DOI":"10.2165\/00003088-199426030-00004","article-title":"Clinical pharmacokinetics of fluoxetine","volume":"26","author":"Altamura","year":"1994","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.biopha.2026.119738_bib71","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1160977","article-title":"Stimulatory effect of fluoxetine and desipramine, but not mirtazapine on C26 colon carcinoma hepatic metastases formation: association with cytokines","volume":"14","author":"Kubera","year":"2023","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.biopha.2026.119738_bib72","doi-asserted-by":"crossref","first-page":"673","DOI":"10.3892\/mmr.2016.6072","article-title":"Fluoxetine protects against methamphetamine\u2011induced lung inflammation by suppressing oxidative stress through the SERT\/p38 MAPK\/Nrf2 pathway in rats","volume":"15","author":"Wang","year":"2017","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.biopha.2026.119738_bib73","series-title":"Antiviral Agents: Cidofovir and Brincidofovir","first-page":"251","author":"Pasikhova","year":"2024"},{"issue":"2","key":"10.1016\/j.biopha.2026.119738_bib74","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.bbmt.2018.09.038","article-title":"A randomized, double-blind, Placebo-controlled phase 3 trial of oral brincidofovir for cytomegalovirus prophylaxis in allogeneic hematopoietic cell transplantation","volume":"25","author":"Marty","year":"2019","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.biopha.2026.119738_bib75","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jcv.2017.09.013","article-title":"Disseminated adenovirus infection after allogeneic stem cell transplant and the potential role of brincidofovir \u2013 case series and 10 year experience of management in an adult transplant cohort","volume":"96","author":"Ramsay","year":"2017","journal-title":"J. Clin. Virol."},{"issue":"4","key":"10.1016\/j.biopha.2026.119738_bib76","doi-asserted-by":"crossref","DOI":"10.3390\/v13040667","article-title":"Broad-spectrum antiviral strategies and nucleoside analogues","volume":"13","author":"Geraghty","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.biopha.2026.119738_bib77","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2021.603309","article-title":"Targeting host cellular factors as a strategy of therapeutic intervention for herpesvirus infections","volume":"11","author":"Asha","year":"2021","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.biopha.2026.119738_bib78","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2024.103036","article-title":"Antiviral efficacy of fluoxetine in early symptomatic COVID-19: an open-label, randomised, controlled, adaptive platform trial (PLATCOV)","volume":"80","author":"Jittamala","year":"2025","journal-title":"EClinicalMedicine"},{"issue":"4","key":"10.1016\/j.biopha.2026.119738_bib79","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1194\/jlr.M012880","article-title":"Crucial role of alkaline sphingomyelinase in sphingomyelin digestion: a study on enzyme knockout mice","volume":"52","author":"Zhang","year":"2011","journal-title":"J. Lipid Res."},{"issue":"16","key":"10.1016\/j.biopha.2026.119738_bib80","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22169001","article-title":"Acid sphingomyelinase, a lysosomal and secretory phospholipase C, is key for cellular phospholipid catabolism","volume":"22","author":"Breiden","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2026.119738_bib81","unstructured":"D. Choezom, Investigating the role of neutral sphingomyelinases in membrane vesicle trafficking, 2022."},{"issue":"4","key":"10.1016\/j.biopha.2026.119738_bib82","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1007\/s12017-010-8120-z","article-title":"Mammalian neutral sphingomyelinases: regulation and roles in cell signaling responses","volume":"12","author":"Wu","year":"2010","journal-title":"Neuromol. Med."},{"issue":"19","key":"10.1016\/j.biopha.2026.119738_bib83","doi-asserted-by":"crossref","first-page":"13784","DOI":"10.1074\/jbc.M511306200","article-title":"Novel tumor necrosis factor-responsive mammalian neutral sphingomyelinase-3 is a C-tail-anchored protein","volume":"281","author":"Krut","year":"2006","journal-title":"J. Biol. Chem."},{"issue":"8","key":"10.1016\/j.biopha.2026.119738_bib84","doi-asserted-by":"crossref","first-page":"3074","DOI":"10.1074\/jbc.M116.762377","article-title":"Sphingosine and sphingosine kinase 1 involvement in endocytic membrane trafficking","volume":"292","author":"Lima","year":"2017","journal-title":"J. Biol. Chem."},{"issue":"2-3","key":"10.1016\/j.biopha.2026.119738_bib85","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S1388-1981(02)00341-4","article-title":"Sphingosine kinase, sphingosine-1-phosphate, and apoptosis","volume":"1585","author":"Maceyka","year":"2002","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.biopha.2026.119738_bib86","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2021.683767","article-title":"The functional role of sphingosine kinase 2","volume":"8","author":"Diaz Escarcega","year":"2021","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.biopha.2026.119738_bib87","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/7685142","article-title":"S1P lyase regulation of thymic egress and oncogenic inflammatory signaling","volume":"2017","author":"Kumar","year":"2017","journal-title":"Mediat. Inflamm."},{"issue":"6463","key":"10.1016\/j.biopha.2026.119738_bib88","doi-asserted-by":"crossref","DOI":"10.1126\/science.aar5551","article-title":"Sphingosine 1-phosphate: lipid signaling in pathology and therapy","volume":"366","author":"Cartier","year":"2019","journal-title":"Science"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226007742?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226007742?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T06:38:42Z","timestamp":1784529522000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332226007742"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":88,"alternative-id":["S0753332226007742"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119738","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acid sphingomyelinase is an age-dependent host cell factor for adenovirus entry and a pharmacological target for synergistic combination therapy with brincidofovir","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119738","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"119738"}}